Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Fabi

Showing results (161-170 of 265) with videos related to

Pageof 27
Sort By:
Journal of Cancer|April 12, 2014
Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational studyTeresa Gamucci, Andrea Michelotti, Laura Pizzuti, et al.
Clinical Breast Cancer|March 28, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective StudyGiovanna Garufi, Luca Mastrantoni, Noemi Maliziola, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
Oncotargets and Therapy|May 23, 2019
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?Marina Elena Cazzaniga, Laura Biganzoli, Laura Cortesi, et al.
Cancers|October 21, 2020
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 LockdownAlessandra Fabi, Patrizia Pugliese, Pina Tiziana Falbo, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
<i>DonnaRosa</i> Project: Exploring Informal Communication Practices Among Breast Cancer SpecialistsAntonella Ferro, Flavia Atzori, Catia Angiolini, et al.
Future Oncology (London, England)|November 29, 2017
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?Alessandra Fabi, Diana Giannarelli, Luca Moscetti, et al.
Journal of Personalized Medicine|September 23, 2022
Prepectoral vs. Submuscular Immediate Breast Reconstruction in Patients Undergoing Mastectomy after Neoadjuvant Chemotherapy: Our Early ExperienceLorenzo Scardina, Alba Di Leone, Ersilia Biondi, et al.
Expert Opinion on Investigational Drugs|June 28, 2007
Aromatase inhibitors in post-menopausal metastatic breast carcinomaPaolo Carlini, Emilio Bria, Diana Giannarelli, et al.
BMC Cancer|March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyRoberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
Pageof 27

Showing results (161-170 of 265) with videos related to

Sort By:
Pageof 27
Journal of Cancer|April 12, 2014
Eribulin mesylate in pretreated breast cancer patients: a multicenter retrospective observational studyTeresa Gamucci, Andrea Michelotti, Laura Pizzuti, et al.
Clinical Breast Cancer|March 28, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective StudyGiovanna Garufi, Luca Mastrantoni, Noemi Maliziola, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
Oncotargets and Therapy|May 23, 2019
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?Marina Elena Cazzaniga, Laura Biganzoli, Laura Cortesi, et al.
Cancers|October 21, 2020
The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 LockdownAlessandra Fabi, Patrizia Pugliese, Pina Tiziana Falbo, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
<i>DonnaRosa</i> Project: Exploring Informal Communication Practices Among Breast Cancer SpecialistsAntonella Ferro, Flavia Atzori, Catia Angiolini, et al.
Future Oncology (London, England)|November 29, 2017
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?Alessandra Fabi, Diana Giannarelli, Luca Moscetti, et al.
Journal of Personalized Medicine|September 23, 2022
Prepectoral vs. Submuscular Immediate Breast Reconstruction in Patients Undergoing Mastectomy after Neoadjuvant Chemotherapy: Our Early ExperienceLorenzo Scardina, Alba Di Leone, Ersilia Biondi, et al.
Expert Opinion on Investigational Drugs|June 28, 2007
Aromatase inhibitors in post-menopausal metastatic breast carcinomaPaolo Carlini, Emilio Bria, Diana Giannarelli, et al.
BMC Cancer|March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyRoberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
Pageof 27